Carmen Albó

2.6k total citations
36 papers, 1.6k citations indexed

About

Carmen Albó is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Carmen Albó has authored 36 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Carmen Albó's work include Lymphoma Diagnosis and Treatment (7 papers), Virus-based gene therapy research (6 papers) and Influenza Virus Research Studies (6 papers). Carmen Albó is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Virus-based gene therapy research (6 papers) and Influenza Virus Research Studies (6 papers). Carmen Albó collaborates with scholars based in Spain, France and Uruguay. Carmen Albó's co-authors include Agustı́n Portela, Paulino Gómez‐Puertas, António Bernad, Pedro López‐Romero, Ana Dopazo, Esperanza Pérez‐Pastrana, Amparo Vivó, Benjamín Fernández‐Gutiérrez, María C. Fernández Tome and Marı́a Dolores Caballero and has published in prestigious journals such as Blood, PLoS ONE and Journal of Virology.

In The Last Decade

Carmen Albó

35 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmen Albó Spain 20 590 513 332 315 288 36 1.6k
Akira Hangaishi Japan 28 1.1k 1.8× 361 0.7× 238 0.7× 499 1.6× 373 1.3× 86 2.7k
A. Amadori Italy 23 454 0.8× 208 0.4× 664 2.0× 132 0.4× 175 0.6× 62 1.6k
Sylvie Fraitag France 26 295 0.5× 403 0.8× 406 1.2× 153 0.5× 567 2.0× 128 2.3k
Jürgen Galle Germany 8 433 0.7× 257 0.5× 143 0.4× 124 0.4× 238 0.8× 11 1.6k
Y Ohtsuki Japan 31 724 1.2× 491 1.0× 703 2.1× 64 0.2× 283 1.0× 144 2.8k
Pei Lin United States 19 508 0.9× 255 0.5× 1.2k 3.6× 237 0.8× 567 2.0× 49 2.4k
Valeri H. Terry United States 16 563 1.0× 175 0.3× 272 0.8× 114 0.4× 74 0.3× 24 1.8k
Gundula Schaumburg‐Lever Germany 23 428 0.7× 488 1.0× 219 0.7× 272 0.9× 587 2.0× 59 2.0k
Sandra Weller France 21 425 0.7× 254 0.5× 1.5k 4.7× 248 0.8× 204 0.7× 30 2.1k
Susan A. Tarlé United States 26 1.4k 2.3× 221 0.4× 158 0.5× 422 1.3× 74 0.3× 30 2.2k

Countries citing papers authored by Carmen Albó

Since Specialization
Citations

This map shows the geographic impact of Carmen Albó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Albó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Albó more than expected).

Fields of papers citing papers by Carmen Albó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Albó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Albó. The network helps show where Carmen Albó may publish in the future.

Co-authorship network of co-authors of Carmen Albó

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Albó. A scholar is included among the top collaborators of Carmen Albó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Albó. Carmen Albó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Albó, Carmen, et al.. (2024). Abolishing Retro-Transduction of Producer Cells in Lentiviral Vector Manufacturing. Viruses. 16(8). 1216–1216. 5 indexed citations
2.
3.
4.
Lucas, Daniel, José M. Delgado‐García, Carmen Albó, et al.. (2013). Increased Learning and Brain Long-Term Potentiation in Aged Mice Lacking DNA Polymerase μ. PLoS ONE. 8(1). e53243–e53243. 14 indexed citations
5.
Lara‐Astiaso, David, Juan Camilo Estrada, Carmen Albó, et al.. (2012). Complement anaphylatoxins C3a and C5a induce a failing regenerative program in cardiac resident cells. Evidence of a role for cardiac resident stem cells other than cardiomyocyte renewal. SpringerPlus. 1(1). 63–63. 26 indexed citations
6.
Estrada, Juan Camilo, Carmen Albó, Alberto Benguría, et al.. (2011). Culture of human mesenchymal stem cells at low oxygen tension improves growth and genetic stability by activating glycolysis. Cell Death and Differentiation. 19(5). 743–755. 226 indexed citations
7.
Calero, Olga, Rafael Hortigüela, Carmen Albó, Jesús de Pedro‐Cuesta, & Miguel Calero. (2009). Allelic discrimination of genetic human prion diseases by real-time PCR genotyping. Prion. 3(3). 146–150. 8 indexed citations
8.
9.
Cuadrado‐Corrales, Natividad, Adolfo Jiménez‐Huete, Carmen Albó, et al.. (2006). Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD. BMC Neurology. 6(1). 25–25. 23 indexed citations
10.
Rodríguez, José A., Marı́a Dolores Caballero, Antonio Gutiérrez, et al.. (2005). Prolonged Survival in Patients with Angioimmunoblastic T-Cell Lymphoma (AIL) after High-Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT). The GELTAMO Experience.. Blood. 106(11). 2082–2082. 2 indexed citations
11.
Álvarez‐Larrán, Alberto, Julio del Río-Garma, C. Ramı́rez, et al.. (2004). Methylene blue‐photoinactivated plasma vs. fresh‐frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Vox Sanguinis. 86(4). 246–251. 55 indexed citations
12.
Lahuerta, Juan José, Carlos Grande, Joaquín Martínez‐López, et al.. (2003). Tandem transplants with different high‐dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Español de Síndromes Linfoproliferativos/Trasplante Autólogo de Médula Ósea phase II trial. British Journal of Haematology. 120(2). 296–303. 30 indexed citations
13.
Gómez‐Puertas, Paulino, Carmen Albó, Esperanza Pérez‐Pastrana, Amparo Vivó, & Agustı́n Portela. (2000). Influenza Virus Matrix Protein Is the Major Driving Force in Virus Budding. Journal of Virology. 74(24). 11538–11547. 215 indexed citations
14.
Mena, Ignacio, et al.. (1999). Mutational Analysis of Influenza A Virus Nucleoprotein: Identification of Mutations That Affect RNA Replication. Journal of Virology. 73(2). 1186–1194. 67 indexed citations
15.
Albó, Carmen, et al.. (1996). [Peritoneal tuberculosis in a patient with chronic lymphatic leukemia in treatment with fludarabine].. PubMed. 41(2). 164–164. 1 indexed citations
16.
Mena, Ignacio, Susana de la Luna, Carmen Albó, et al.. (1994). Synthesis of biologically active influenza virus core proteins using a vaccinia virus-T7 RNA polymerase expression system. Journal of General Virology. 75(8). 2109–2114. 60 indexed citations
17.
Fuente, Javier de la, Carmen Albó, Ana Rodrı́guez, B. Sopeña, & Claudio Martínez. (1994). Bordetella bronchiseptica pneumonia in a patient with AIDS.. Thorax. 49(7). 719–720. 22 indexed citations
18.
Martín, Javier, Carmen Albó, Juan Ortı́n, Jose ́A. Melero, & Agustı́n Portela. (1992). In vitro reconstitution of active influenza virus ribonucleoprotein complexes using viral proteins purified from infected cells. Journal of General Virology. 73(7). 1855–1859. 28 indexed citations
19.
Cristina, Juan, Andrés Moyá, Juan Arbiza, et al.. (1991). Evolution of the G and P genes of human respiratory syncytial virus (subgroup A) studied by the RNase A mismatch cleavage method. Virology. 184(1). 210–218. 21 indexed citations
20.
Cristina, Juan, Juan Antonio López, Carmen Albó, et al.. (1990). Analysis of genetic variability in human respiratory syncytial virus by the RNase a mismatch cleavage method: Subtype divergence and heterogeneity. Virology. 174(1). 126–134. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akira Hangaishi Breakdown of academic impact, for papers by A. Amadori Breakdown of academic impact, for papers by Sylvie Fraitag Breakdown of academic impact, for papers by Jürgen Galle Breakdown of academic impact, for papers by Y Ohtsuki Breakdown of academic impact, for papers by Pei Lin Breakdown of academic impact, for papers by Valeri H. Terry Breakdown of academic impact, for papers by Gundula Schaumburg‐Lever Breakdown of academic impact, for papers by Sandra Weller Breakdown of academic impact, for papers by Susan A. Tarlé
Rankless by CCL
2026